Cai, Xuezhu, Vyshak Chandra, Yangming Ou, Kyrre Emblem, Alona Muzikansky, John Evans, Jayashree Kalpathy-Cramer, et al. 2015. “Phase II Study of Tivozanib, an Oral VEGFR Inhibitor, in Patients With Recurrent Glioblastoma..” Last updated on 02/27/2023
